Back to companies

Biohaven Pharmaceutical Holding Company Ltd: Overview

Biohaven Pharmaceutical Holding Company Ltd (Biohaven) is a clinical-stage biopharmaceutical company. The company develops late-stage product candidates for neurological diseases. The company develops small molecule CGRP receptor antagonist platform that includes two product candidates such as rimegepant for the acute treatment of migraine, and zavegepant for the prevention of a chronic and episodic migraine. Its glutamate modulation platform includes product candidates such as trigriluzole and BHV-4157 for the treatment of obsessive-compulsive disorder (OCD) and Alzheimer’s disease; BHV-0223 for the treatment of amyotrophic lateral sclerosis (ALS); and BHV-5000 for treating symptoms associated with Rett syndrome and other neuropsychiatric indications. Biohaven is headquartered in New Haven, Connecticut, the US.

Headquarters United States of America

Address 215 Church St, New Haven, Connecticut, 06510-1803


Telephone 1 203 4040410

No of Employees 928

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange BHVN (NYSE)

Revenue (2020) $462.5M 626.9% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX -10.4% (2020 vs 2019)

Market Cap* $10.5B

Net Profit Margin (2020) XXX 84.8% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Biohaven Pharmaceutical Holding Company Ltd

140+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Biohaven Pharmaceutical Holding Company Ltd’s relevant decision makers and contact details.

90+

Clinical Trials

Determine Biohaven Pharmaceutical Holding Company Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Pipeline Drugs

Identify which of Biohaven Pharmaceutical Holding Company Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

8

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

8

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

Marketed Drugs

Understand Biohaven Pharmaceutical Holding Company Ltd’s commercialized product portfolio to stay one step ahead of the market.

9

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Biohaven Pharmaceutical Holding Company Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products
Pipeline
Rimegepant (BHV-3000):
Migraine
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In May, the company agreed to be acquired by Pfizer Inc for US$11.6 billion.
2022 Others In April, the company announced the publication of research about levels of migraine-related disability were associated with increased HCRU costs.
2022 Acquisitions/Mergers/Takeovers In March, the company acquired the US-based Channel Biosciences, LLC from Knopp Biosciences LLC.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Biohaven Pharmaceutical Holding Company Ltd La Jolla Pharmaceutical Company Athersys Inc Arena Pharmaceuticals Inc Astellas Institute for Regenerative Medicine
Headquarters United States of America United States of America United States of America United States of America United States of America
City New Haven Waltham Cleveland San Diego Westborough
State/Province Connecticut Massachusetts Ohio California Massachusetts
No. of Employees 928 61 104 448 -
Entity Type Public Public Public Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Vlad Coric, MD Chairman Executive Board 2021 -
Cliff Bechtold General Manager - Biohaven Ireland; President - Biohaven Ireland; Chief Compliance Officer Senior Management - -
Elyse Stock Chief Medical Officer Senior Management 2019 63
Charles Conway, Ph.D. Chief Scientific Officer Senior Management 2017 59
John Donnie McGrath Chief Corporate Strategy and Business Development Senior Management - -
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer